Independent Financial Group’s Insmed INSM Stock Holding History

Independent Financial Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,113	Closed	-$716K	–	1486
2025 Q4	$716K	Buy	4,113 +2,578	+168%	+$470K	0.02%	749
2025 Q3	$221K	Buy	+1,535	New	+$188K	0.01%	1240

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Independent Financial Group's INSM Position: Q1 2026 in Review

Independent Financial Group sold out of Insmed (INSM) in Q1 2026, closing a stake of 4,113 shares — an estimated $716K sold.

Independent Financial Group first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $716K in Q4 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Independent Financial Group reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Independent Financial Group sold 4,113 Insmed shares in Q1 2026, an estimated $716K.
Independent Financial Group first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
Independent Financial Group's Insmed position peaked at $716K in Q4 2025.
673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Independent Financial Group's 13F filing for Q1 2026, filed 5 May 2026.